Page last updated: 2024-08-22

trimetazidine and Heart Failure

trimetazidine has been researched along with Heart Failure in 69 studies

Research

Studies (69)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (2.90)18.2507
2000's28 (40.58)29.6817
2010's29 (42.03)24.3611
2020's10 (14.49)2.80

Authors

AuthorsStudies
Arduini, A; Ceccarelli, SM; Chomienne, O; Gubler, M1
Aronov, DM; Bubnova, MG1
Chen, K; Chen, N; Guo, D; Jiao, H; Li, Y; Liu, W; Song, L; Sun, Y; Wei, X; Xue, Y; Yang, K; Yu, M; Yu, T1
Bahrudin, U; Harjoko, RP; Herminingsih, S; Maharani, N; Sobirin, MA; Tsutsui, H; Uddin, I1
Min, Z; Qiuhong, S; Ran, Z; Xuelu, L; Yong, M1
Lu, Y; Ni, H; Shi, H; Sun, Y; Wang, F1
Chang, J; Choi, HY; Hong, SP; Jin, ES; Kong, MG; Kwon, SS; Park, GM; Park, RW; Park, S1
Allaart, CP; Bakermans, AJ; Bronzwaer, PNA; de Man, FS; Geurkink, KTJ; Handoko, ML; Kok, WEM; Nederveen, AJ; Oosterveer, FTP; van de Bovenkamp, AA; van Rossum, AC1
Thadani, U1
Bohdan, M; Gruchała, M; Moryś, J; Niedoszytko, P; Stopczyńska, I; Wiśniewski, P1
Fu, B; Ma, S; Zhang, X1
Breedt, E; Essop, MF; Lacerda, L1
Kavtaradze, N; Saganelidze, K1
Lu, X; Ma, X; Wang, J; Wen, J; Yang, Y; Zhang, L; Zhao, Y1
Coats, CJ; Elliott, PM; Frenneaux, MP; Hyland, R; McKenna, WJ; Moss, L; Omar, R; Pantazis, AA; Pavlou, M; Protonotarios, A; Rantell, K; Tome, M; Watkinson, OT1
Guo, T; Wang, J1
Altamirano, R; Castro, PF; Chiong, M; Concepción, R; Enriquez, A; García, L; Jalil, JE; Lavandero, S; Mellado, R; Quintana, JC; Rossel, V; Sepúlveda, L; Sepúlveda, P; Verdejo, HE; Winter, JL1
Andrikopoulos, G; Manolis, A; Tsioufis, K1
Chen, J; Zhou, X1
Banach, M; Chrusciel, P; Rysz, J1
Fragasso, G; Gowdak, LH; Hamid, MA; Jourdain, P; Lopaschuk, GD; Lopatin, YM; Ponikowski, P; Rosano, GM; Seferovic, PM; Vinereanu, D1
Sun, A; Wang, P; Xu, L1
Heggermont, WA; Heymans, S; Papageorgiou, AP; van Bilsen, M1
Osmolovskaya, YF; Tereshchenko, SN; Zhirov, IV1
Arioli, F; Bassanelli, G; Fragasso, G; Margonato, A; Salerno, A; Spoladore, R1
Akdag, S; Gumrukcuoglu, HA; Gunes, Y; Guntekin, U; Tuncer, M1
Di Napoli, P1
Tang, WH1
Barsotti, A; Di Napoli, P1
Gunes, Y; Guntekin, U; Sahin, M; Tuncer, M2
Di Napoli, P; Taccardi, AA1
Bunc, M; Vrtovec, B; Zemljic, G1
Arioli, F; Cera, M; Facchini, A; Fragasso, G; Gardini, C; Godino, C; Margonato, A; Marinosci, G; Montanaro, C; Salerno, A; Spoladore, R1
Magnitskaia, OV; Sedova, EM1
Mellana, WM; Mohan, D; Palaniswamy, C; Selvaraj, DR1
Chirkov, YY; Horowitz, JD; Kennedy, JA; Sverdlov, AL1
Qizhu, T; Wenmeng, W1
Gao, D; Hao, G; Meng, Z; Ning, N; Niu, X1
Ashrafian, H; Neubauer, S1
Arioli, F; Bassanelli, G; Calori, G; Cuko, A; Fragasso, G; Lattuada, G; Luzi, L; Margonato, A; Perseghin, G; Ragogna, F; Salerno, A; Scollo, A; Spoladore, R1
Kulikov, KG; Shal'nova, SA; Shkol'nik, EL; Vasiuk, IuA1
Ivanova, EP; Morozova, TE; Rykova, SM1
Ge, J; Jiang, H; Lu, Y; Sun, A; Zhang, L; Zou, Y1
Liu, F; Liu, J; Liu, W; Wang, Y; Yin, L; Yu, B; Zhang, L1
Alberti, L; Baek, SH; Belardinelli, R; Calori, G; Di Napoli, P; Fragasso, G; Kang, SM; Marazzi, G; Margonato, A; Rosano, G; Sahakyan, L; Sanosyan, A; Sisakian, H; Vitale, C1
Blatter, LA; Dedkova, EN; Seidlmayer, LK1
Maisch, B; Rupp, H; Zarain-Herzberg, A1
Bescond-Jacquet, A; Grynberg, A; Helies-Toussaint, C; Lucien, A; Morin, D; Tabbi-Anneni, I1
Ma, QL; Xie, Y; Zhang, SD1
Andreadou, I; Cicchitelli, G; Ferrari, R; Guardigli, G; Merli, E1
Kutuzova, AE; Nedoshivin, AO; Nesterova, IV; Sitnikova, MIu; Sveshnikov, IuG1
Malmberg, K; Rydén, L; Thrainsdottir, IS; von Bibra, H1
Efimova, I; Filippov, EA; Garganeeva, AA; Kaliuzhin, VV; Pushnikova, EIu; Sankevich, qV; Stepacheva, TA; Tepliakov, AT; Zavadovskiĭ, KV1
Essop, MF; Opie, LH1
Fedorova, TA; Il'ina, IuV; Rybakova, MK; Sotnikova, TI1
McMurray, JJ; O'Meara, E1
Calori, G; De Cobelli, F; Del Maschio, A; Esposito, A; Fragasso, G; Lattuada, G; Margonato, A; Palloshi, A; Perseghin, G; Scifo, P1
Jackson, G1
Lopaschuk, GD1
Iushchuk, EN; Khadzegova, AB; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK1
Belardinelli, R; Purcaro, A; Solenghi, M; Volpe, L1
Iushchuk, EN; Khadzegova, AB; Sadulaeva, IA; Shkol'nik, EL; Vakhromeeva, MN; Vasiuk, IuA; Vit'ko, NK1
Barkhudaryan, A; Sisakian, H; Torgomyan, A1
Barsotti, A; Di Giovanni, P; Di Napoli, P; Gaeta, MA; Taccardi, AA1
Ashrafian, H; Frenneaux, MP; Williams, L1
Demidova, IV; Drozdov, VN; Levchuk, NN; Tereshchenko, SN1
Cokkinos, DV1
Guarnieri, C; Muscari, C1

Reviews

20 review(s) available for trimetazidine and Heart Failure

ArticleYear
[MODERN ASPECTS OF DIAGNOSIS AND TREATMENT OF HEART FAILURE, AS A MANIFESTATION OF ANTHRACYCLINE CARDIOTOXICITY (REVIEW)].
    Georgian medical news, 2018, Issue:278

    Topics: Anthracyclines; Antineoplastic Agents; Biomarkers; Cardiomyopathies; Cardiotonic Agents; Cardiotoxicity; Echocardiography; Elapid Venoms; Heart; Heart Failure; Humans; Ivabradine; Natriuretic Peptide, C-Type; Neoplasms; Survival Analysis; Trastuzumab; Trimetazidine; Troponin I

2018
Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis.
    Medicine, 2018, Volume: 97, Issue:51

    Topics: Cardiovascular Agents; Drug Therapy, Combination; Drugs, Chinese Herbal; Heart Failure; Humans; Myocardial Ischemia; Randomized Controlled Trials as Topic; Trimetazidine

2018
Metabolic remodeling in chronic heart failure.
    Journal of Zhejiang University. Science. B, 2013, Volume: 14, Issue:8

    Topics: Adenosine Triphosphate; Carbohydrate Metabolism; Carnitine; Energy Metabolism; Fatty Acids; Fetal Heart; Glucose; Heart Failure; Humans; Neurotransmitter Agents; Thiamine; Trimetazidine; Ventricular Remodeling

2013
Trimetazidine and cardioprotection: facts and perspectives.
    Angiology, 2015, Volume: 66, Issue:3

    Topics: Angina, Stable; Cardiotonic Agents; Chronic Disease; Heart Failure; Humans; Patient Selection; Practice Guidelines as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents

2015
Is treatment with trimetazidine beneficial in patients with chronic heart failure?
    PloS one, 2014, Volume: 9, Issue:5

    Topics: C-Reactive Protein; Chronic Disease; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; PubMed; Randomized Controlled Trials as Topic; Stroke Volume; Trimetazidine; Vasodilator Agents

2014
Defining the role of trimetazidine in the treatment of cardiovascular disorders: some insights on its role in heart failure and peripheral artery disease.
    Drugs, 2014, Volume: 74, Issue:9

    Topics: Cardiovascular Agents; Cardiovascular Diseases; Heart Failure; Humans; Peripheral Arterial Disease; Trimetazidine

2014
Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure.
    International journal of cardiology, 2016, Jan-15, Volume: 203

    Topics: Energy Metabolism; Heart Failure; Humans; Myocardium; Prognosis; Treatment Outcome; Trimetazidine; Vasodilator Agents

2016
Energy Remodeling, Mitochondrial Disorder and Heart Failure.
    Current pharmaceutical design, 2016, Volume: 22, Issue:31

    Topics: Aminoimidazole Carboxamide; Animals; Energy Metabolism; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Mitochondrial Diseases; Ribonucleotides; Thiazolidinediones; Trimetazidine

2016
Metabolic support for the heart: complementary therapy for heart failure?
    European journal of heart failure, 2016, Volume: 18, Issue:12

    Topics: Acetyl-CoA C-Acyltransferase; Cardiovascular Agents; Carnitine; Carnitine O-Palmitoyltransferase; Dichloroacetic Acid; Energy Metabolism; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Oxidation-Reduction; Perhexiline; Ranolazine; Stroke Volume; Trimetazidine

2016
[Trimetazidine in the Treatment of Chronic HeartFailure].
    Kardiologiia, 2016, Volume: 56, Issue:1

    Topics: Chronic Disease; Heart Failure; Humans; Trimetazidine; Vasodilator Agents

2016
Metabolic therapy of heart failure.
    Current pharmaceutical design, 2008, Volume: 14, Issue:25

    Topics: Animals; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Fatty Acids, Nonesterified; Heart Failure; Humans; Myocardium; Perhexiline; Trimetazidine

2008
The metabolic approach in patients with heart failure: effects on left ventricle remodeling.
    Current pharmaceutical design, 2009, Volume: 15, Issue:8

    Topics: Glucagon-Like Peptide 1; Heart Failure; Humans; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling

2009
Prognostic relevance of metabolic approach in patients with heart failure.
    Current pharmaceutical design, 2009, Volume: 15, Issue:8

    Topics: Heart Failure; Humans; Prognosis; Risk Assessment; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Remodeling

2009
Trimetazidine: the future of cardiac function?
    Future cardiology, 2009, Volume: 5, Issue:5

    Topics: Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents

2009
Metabolic modulation: a new therapeutic target in treatment of heart failure.
    American journal of therapeutics, 2011, Volume: 18, Issue:6

    Topics: Acetanilides; Carnitine O-Palmitoyltransferase; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Glucose; Heart Failure; Humans; Mitochondria, Heart; Myocytes, Cardiac; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents

2011
Modulation of myocardial metabolism: an emerging therapeutic principle.
    Current opinion in cardiology, 2010, Volume: 25, Issue:4

    Topics: Acetanilides; Amiodarone; Cardiovascular Agents; Heart Failure; Humans; Hypertrophy, Left Ventricular; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Reperfusion; Myocardium; Perhexiline; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents

2010
Trimetazidine: a meta-analysis of randomised controlled trials in heart failure.
    Heart (British Cardiac Society), 2011, Volume: 97, Issue:4

    Topics: Acetyl-CoA C-Acyltransferase; Adult; Chronic Disease; Enzyme Inhibitors; Exercise Tolerance; Heart Failure; Humans; Randomized Controlled Trials as Topic; Stroke Volume; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Remodeling

2011
Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis.
    Journal of the American College of Cardiology, 2012, Mar-06, Volume: 59, Issue:10

    Topics: Disease Progression; Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Remodeling

2012
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
    Herz, 2002, Volume: 27, Issue:7

    Topics: Acetanilides; Angina Pectoris; Animals; Calcium; Cardiovascular Agents; Clinical Trials as Topic; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Methylhydrazines; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Trimetazidine; Up-Regulation; Vasodilator Agents

2002
Metabolic modulation and optimization of energy consumption in heart failure.
    The Medical clinics of North America, 2003, Volume: 87, Issue:2

    Topics: Acetanilides; Cardiac Pacing, Artificial; Cardiotonic Agents; Carnitine; Energy Metabolism; Heart Failure; Humans; Piperazines; Ranolazine; Trimetazidine

2003

Trials

21 trial(s) available for trimetazidine and Heart Failure

ArticleYear
Trimetazidine improves left ventricular global longitudinal strain value in patients with heart failure with reduced ejection fraction due to ischemic heart disease.
    Drug discoveries & therapeutics, 2022, Sep-17, Volume: 16, Issue:4

    Topics: Aged; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Stroke Volume; Trimetazidine; Ventricular Dysfunction, Left

2022
Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross-over trial.
    ESC heart failure, 2023, Volume: 10, Issue:5

    Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Female; Heart Failure; Humans; Male; Phosphocreatine; Stroke Volume; Trimetazidine

2023
Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study.
    Cardiology journal, 2022, Volume: 29, Issue:4

    Topics: Aged; Chronic Disease; Cross-Over Studies; Heart Failure; Humans; Middle Aged; Prospective Studies; Quality of Life; Stroke Volume; Trimetazidine; Vasodilator Agents; Ventricular Function, Left

2022
Effect of Trimetazidine Dihydrochloride Therapy on Exercise Capacity in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.
    JAMA cardiology, 2019, 03-01, Volume: 4, Issue:3

    Topics: Administration, Oral; Adult; Aged; Cardiomyopathy, Hypertrophic; Exercise Tolerance; Fatty Acids; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Open Bite; Oxygen Consumption; Quality of Life; Trimetazidine; United Kingdom; Vasodilator Agents

2019
Effects of trimetazidine in nonischemic heart failure: a randomized study.
    Journal of cardiac failure, 2014, Volume: 20, Issue:3

    Topics: Adult; Aged; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Radionuclide Imaging; Treatment Outcome; Trimetazidine; Vasodilator Agents

2014
The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
    Pacing and clinical electrophysiology : PACE, 2009, Volume: 32, Issue:2

    Topics: Chemotherapy, Adjuvant; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2009
Improved left and right ventricular functions with trimetazidine in patients with heart failure: a tissue Doppler study.
    Heart and vessels, 2009, Volume: 24, Issue:4

    Topics: Aged; Diabetes Complications; Drug Therapy, Combination; Echocardiography, Doppler; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Ventricular Function, Right

2009
Trimetazidine shortens QTc interval in patients with ischemic heart failure.
    Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:1

    Topics: Aged; Angiography; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Regression Analysis; Trimetazidine; Vasodilator Agents; Ventricular Function, Left

2010
Beneficial electrophysiological effects of trimetazidine in patients with postischemic chronic heart failure.
    Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:1

    Topics: Aged; Aged, 80 and over; Antisocial Personality Disorder; Arrhythmias, Cardiac; Chronic Disease; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Risk Factors; Trimetazidine; Vasodilator Agents

2010
[A clinical experience of taurine and trimetazidine use in premenopausal women with chronic heart failure].
    Kardiologiia, 2010, Volume: 50, Issue:1

    Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Middle Aged; Premenopause; Severity of Illness Index; Taurine; Treatment Outcome; Trimetazidine; Vasodilator Agents

2010
Effect of partial inhibition of fatty acid oxidation by trimetazidine on whole body energy metabolism in patients with chronic heart failure.
    Heart (British Cardiac Society), 2011, Volume: 97, Issue:18

    Topics: Aged; Calorimetry; Chronic Disease; Echocardiography; Energy Metabolism; Fatty Acids; Female; Heart Failure; Humans; Male; Oxidation-Reduction; Stroke Volume; Trimetazidine; Vasodilator Agents

2011
[The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
    Kardiologiia, 2011, Volume: 51, Issue:6

    Topics: Aged; Angina Pectoris; Cardiotonic Agents; Drug Monitoring; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nitro Compounds; Russia; Severity of Illness Index; Sex Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents

2011
[Effects of trimetazidine on serum oxygen free radicals in congestive heart failure].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2002, Dec-28, Volume: 27, Issue:6

    Topics: Adult; Aged; Female; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Trimetazidine; Vasodilator Agents; Ventricular Function, Left

2002
[Effect of treatment with trimethazidine on characteristics of arrhythmia and indicators of heart rhythm in patients with chronic cardiac failure].
    Terapevticheskii arkhiv, 2003, Volume: 75, Issue:3

    Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Heart Failure; Humans; Male; Middle Aged; Trimetazidine

2003
Effects of trimetazidine on left ventricular function in patients with type 2 diabetes and heart failure.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:1

    Topics: Aged; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Oxygen Consumption; Trimetazidine; Vasodilator Agents; Ventricular Function, Left

2004
[Anti-ischemic effects of trimetazidine in patients with post-infarction heart failure].
    Klinicheskaia meditsina, 2004, Volume: 82, Issue:5

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Trimetazidine; Vasodilator Agents

2004
[Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
    Klinicheskaia meditsina, 2004, Volume: 82, Issue:11

    Topics: Aged; Aged, 80 and over; Bisoprolol; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Sympathomimetics; Trimetazidine; Vasodilator Agents

2004
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    European heart journal, 2006, Volume: 27, Issue:8

    Topics: Adenosine Triphosphate; Aged; Cross-Over Studies; Double-Blind Method; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Magnetic Resonance Angiography; Male; Phosphocreatine; Prospective Studies; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2006
Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect.
    European heart journal, 2007, Volume: 28, Issue:9

    Topics: Antioxidants; Cardiomyopathy, Dilated; Chronic Disease; Endothelium, Vascular; Female; Heart Failure; Humans; Male; Middle Aged; Trimetazidine; Vasodilation; Vasodilator Agents

2007
[Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:2

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Agents; Chronic Disease; Combined Modality Therapy; Diuretics; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Methylhydrazines; Middle Aged; Positron-Emission Tomography; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2007
Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Journal of cardiovascular pharmacology, 2007, Volume: 50, Issue:5

    Topics: Aged; C-Reactive Protein; Cardiomyopathy, Dilated; Echocardiography; Exercise Test; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Stroke Volume; Survival Rate; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left; Walking

2007

Other Studies

28 other study(ies) available for trimetazidine and Heart Failure

ArticleYear
Carnitine palmitoyltransferase (CPT) modulators: a medicinal chemistry perspective on 35 years of research.
    Journal of medicinal chemistry, 2011, May-12, Volume: 54, Issue:9

    Topics: Animals; Carnitine; Carnitine O-Palmitoyltransferase; Catalytic Domain; Diabetes Mellitus, Type 2; Energy Metabolism; Enzyme Activators; Ethylene Oxide; Heart Failure; Humans; Insulin Resistance; Isoenzymes; Lipid Metabolism; Myocardial Ischemia; Organ Specificity; Protein Conformation; Sequence Homology, Amino Acid; Stereoisomerism

2011
Efficacy of trimetazidine - an inhibitor of free fatty acids oxidation in the treatment of patients with stable angina pectoris and heart failure.
    Kardiologiia, 2021, Nov-30, Volume: 61, Issue:11

    Topics: Angina, Stable; Fatty Acids, Nonesterified; Heart Failure; Humans; Stroke Volume; Trimetazidine

2021
Protective Effect of Trimetazidine on Potassium Ion Homeostasis in Myocardial Tissue in Mice with Heart Failure.
    BioMed research international, 2022, Volume: 2022

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Heart Failure; Homeostasis; Mice; Potassium; Sodium; Trimetazidine

2022
Effectiveness of Trimetazidine in Patients with Chronic Heart Failure Stratified by the Expression of Soluble Suppression of Tumorigenicity-2 (sST2): A Prospective Cohort Study.
    Advances in therapy, 2022, Volume: 39, Issue:12

    Topics: Biomarkers; Chronic Disease; Heart Failure; Humans; Prospective Studies; Quality of Life; Trimetazidine

2022
Observation of Curative Effect of Trimetazidine Combined with Metoprolol in Elderly Patients with Coronary Heart Disease Complicated with Heart Failure and the Effect of Myocardial Remodeling by Integrated Traditional Chinese and Western Medicine.
    BioMed research international, 2022, Volume: 2022

    Topics: Aged; Cardiovascular Diseases; China; Coronary Disease; Glucose; Heart Failure; Humans; Metoprolol; Middle Aged; Trimetazidine

2022
Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization.
    Journal of cardiovascular pharmacology, 2023, 10-01, Volume: 82, Issue:4

    Topics: Angina Pectoris; Coronary Vessels; Heart Failure; Humans; Treatment Outcome; Trimetazidine; Vasodilator Agents

2023
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?
    International journal of cardiology, 2020, 02-01, Volume: 300

    Topics: Angina Pectoris; Heart Failure; Humans; Myocardial Ischemia; Trimetazidine

2020
Effects of trimetazidine in combination with bisoprolol in patients with chronic heart failure and concomitant chronic obstructive pulmonary disease: A protocol for systematic review and meta-analysis.
    Medicine, 2021, Apr-16, Volume: 100, Issue:15

    Topics: Adrenergic beta-1 Receptor Antagonists; Bisoprolol; Chronic Disease; Drug Therapy, Combination; Heart Failure; Humans; Meta-Analysis as Topic; Observational Studies as Topic; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research Design; Systematic Reviews as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents

2021
Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure.
    PloS one, 2017, Volume: 12, Issue:6

    Topics: Acute Disease; Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Female; Heart; Heart Failure; Heart Rate; In Vitro Techniques; Male; Mice; Mice, Obese; Models, Biological; Sex Factors; Trimetazidine; Ventricular Function

2017
The metabolic treatment of coronary artery disease and heart failure.
    Current pharmaceutical design, 2009, Volume: 15, Issue:8

    Topics: Carnitine O-Palmitoyltransferase; Coronary Artery Disease; Epoxy Compounds; Heart Failure; Humans; Perhexiline; Trimetazidine; Vasodilator Agents

2009
The effects of trimetazidine on heart rate variability in patients with heart failure.
    Arquivos brasileiros de cardiologia, 2009, Volume: 93, Issue:2

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Treatment Outcome; Trimetazidine; Ultrasonography; Vasodilator Agents

2009
Early administration of trimetazidine may prevent or ameliorate diabetic cardiomyopathy.
    Medical hypotheses, 2011, Volume: 76, Issue:2

    Topics: Animals; Diabetes Mellitus; Diabetic Cardiomyopathies; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Models, Theoretical; Myocardial Ischemia; Myocardium; Research Design; Risk Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents

2011
Metabolic modulation in heart failure: high time for a definitive clinical trial.
    Heart (British Cardiac Society), 2011, Volume: 97, Issue:4

    Topics: Acetyl-CoA C-Acyltransferase; Chronic Disease; Enzyme Inhibitors; Heart Failure; Humans; Meta-Analysis as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents

2011
[Clinico-economical aspects of application of trimetazidine MB in patients with chronic heart failure and cardiac rhythm disturbances].
    Kardiologiia, 2011, Volume: 51, Issue:9

    Topics: Aged; Arrhythmias, Cardiac; Chronic Disease; Costs and Cost Analysis; Disease Management; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Monitoring, Physiologic; Remission Induction; Severity of Illness Index; Trimetazidine; Vasodilator Agents

2011
Trimetazidine improves right ventricular function by increasing miR-21 expression.
    International journal of molecular medicine, 2012, Volume: 30, Issue:4

    Topics: Animals; Cells, Cultured; Heart Failure; Heart Ventricles; MicroRNAs; Rats; Rats, Sprague-Dawley; Trimetazidine; Up-Regulation; Vasodilator Agents; Ventricular Dysfunction, Right; Ventricular Function, Right

2012
Effect of partial fatty acid oxidation inhibition with trimetazidine on mortality and morbidity in heart failure: results from an international multicentre retrospective cohort study.
    International journal of cardiology, 2013, Mar-10, Volume: 163, Issue:3

    Topics: Aged; Aged, 80 and over; Cohort Studies; Fatty Acids; Female; Follow-Up Studies; Heart Failure; Humans; Internationality; Male; Middle Aged; Morbidity; Oxidation-Reduction; Retrospective Studies; Treatment Outcome; Trimetazidine; Vasodilator Agents

2013
Mitochondria-mediated cardioprotection by trimetazidine in rabbit heart failure.
    Journal of molecular and cellular cardiology, 2013, Volume: 59

    Topics: Acetyl-CoA C-Acyltransferase; Animals; Calcium; Electron Transport; Heart Failure; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Nitric Oxide Synthase; Rabbits; Reactive Oxygen Species; Trimetazidine

2013
Prevention of heart failure in rats by trimetazidine treatment: a consequence of accelerated phospholipid turnover?
    The Journal of pharmacology and experimental therapeutics, 2003, Volume: 304, Issue:3

    Topics: Animals; Disease Models, Animal; Heart Failure; Male; Natriuretic Peptide, Brain; Organ Size; Phospholipids; Rats; Rats, Wistar; Receptors, Adrenergic; Trimetazidine; Vasodilator Agents

2003
Metabolic therapy for heart failure.
    European heart journal, 2004, Volume: 25, Issue:20

    Topics: Fatty Acids, Nonesterified; Heart Failure; Humans; Mitochondria; Myocardial Contraction; Oxygen; Quality of Life; Trimetazidine; Vasodilator Agents

2004
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
    Heart (British Cardiac Society), 2005, Volume: 91, Issue:2

    Topics: Blood Glucose; Fatty Acids, Nonesterified; Heart Failure; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents

2005
Metabolic approach to heart failure - evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis.
    International journal of clinical practice, 2006, Volume: 60, Issue:8

    Topics: Heart Failure; Humans; Prognosis; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left

2006
Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure.
    Seminars in cardiothoracic and vascular anesthesia, 2006, Volume: 10, Issue:3

    Topics: Animals; Dichloroacetic Acid; Fatty Acids; Glucose; Heart Failure; Humans; Insulin; Myocardium; Trimetazidine

2006
[Possibilities of myocardial cytoprotection in complex treatment of patients with chronic heart failure].
    Kardiologiia, 2006, Volume: 46, Issue:11

    Topics: Aged; Cytoprotection; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Trimetazidine; Vasodilator Agents

2006
The effect of trimetazidine on left ventricular systolic function and physical tolerance in patients with ischaemic cardiomyopathy.
    Acta cardiologica, 2007, Volume: 62, Issue:5

    Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Exercise Test; Exercise Tolerance; Female; Health Status Indicators; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Motor Activity; Myocardial Ischemia; Prospective Studies; Stroke Volume; Systole; Trimetazidine; Vasodilator Agents

2007
The pathophysiology of heart failure: a tale of two old paradigms revisited.
    Clinical medicine (London, England), 2008, Volume: 8, Issue:2

    Topics: Cardiovascular Agents; Cardiovascular Physiological Phenomena; Clinical Trials as Topic; Heart Failure; Humans; Metabolic Networks and Pathways; Perhexiline; Trimetazidine; Vasodilator Agents

2008
[Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].
    Terapevticheskii arkhiv, 1998, Volume: 70, Issue:6

    Topics: Acid Phosphatase; Adult; Aged; Biomarkers; Blood Coagulation Factors; Cholesterol, HDL; Chronic Disease; Creatinine; Female; Follow-Up Studies; Heart Failure; Hemostasis; Humans; Male; Middle Aged; Plasma; Treatment Outcome; Triglycerides; Trimetazidine; Vasodilator Agents

1998
Can metabolic manipulation reverse myocardial dysfunction?
    European heart journal, 2001, Volume: 22, Issue:23

    Topics: Heart Failure; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents

2001
Beneficial effects of trimetazidine on mitochondrial function and superoxide production in the cardiac muscle.
    Cardiovascular drugs and therapy, 1990, Volume: 4 Suppl 4

    Topics: Animals; Heart Failure; Male; Mitochondria, Heart; Monocrotaline; Plants, Toxic; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Senecio; Superoxides; Trimetazidine

1990